Sky Labs

₩8,070As of Sun 8 Nov 2026, 12:00 UTC

KOSDAQ:386380Healthcare

Country South Korea

PE (Fwd) —

TSR 10Y CAGR —

Div yield —

ROE —

Medical Devices

Beta (5Y) —

PE TTM —

TSR TTM —

Mkt cap ₩151.4B

ROIC —

SE Grade™

—

Value

—

Quality

Moat

—

1Y Price

Reference

₩8,714

—

7.98%

—

TTM

FYE 31 Dec KRW

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

7.936

Revenue₩B

—

0.481

0.589

4.091

7.936

11.59

154.64%

—

93.99

Revenue growth%

—

22.60

594.22

93.99

46.07

93.99

—

49.27

Gross margin%

—

(318.56)

(221.43)

(26.21)

49.27

55.34

(123.82)

—

(185.55)

Operating margin%

—

(1797.16)

(1323.71)

(286.73)

(185.55)

(100.00)

(805.22)

—

(793.80)

Net margin%

—

(727.31)

(2351.73)

(309.66)

(793.80)

(100.00)

(760.56)

—

P/E ratio (avg)x

—

EV/EBITx

—

(29.83)

FCF yield (avg)%

—

(24.36)

—

(178.87)

FCF margin%

—

(1997.44)

(1181.36)

(253.18)

(178.87)

(100.00)

(717.27)

—

0.225

FCF / Net incomex

—

2.746

0.502

0.818

0.225

—

0.660

—

ROIC%

—

(159.92)

—

Return on equity%

—

(58.97)

—

(208.72)

Return on assets%

—

(29.94)

(54.68)

(46.10)

(208.72)

(62.36)

(50.39)

—

(10,684)

EPS₩

—

(49,298)

(97,215)

(2,272)

(10,684)

(1,966)

—

(370.25)

EPS growth%

—

(97.20)

97.66

(370.25)

81.60

(97.20)

—

4,317

Bookvalue per sh₩

—

(445,449)

(315,101)

(10,107)

4,317

2,351

—

(2,407)

FCF per share₩

—

(135,389)

(48,835)

(1,858)

(2,407)

(1,966)

—

Dividend per sh₩

—

Div yield (avg)%

—

Payout ratio%

—

5.896

Shares (diluted)M

—

0.071

0.143

5.575

5.896

◌5.896

336.48%

—

(5.75)

Buyback yield%

—

(101.04)

(3811.26)

(5.75)

◌—

(101.04)

—

0.087

D/E ratiox

—

(0.062)

(0.041)

(0.036)

0.087

0.159

(0.038)

—

29.38

Enterprise value₩B

—

40.97

—

LT debt₩M

—

Peers (US$110.5M)

Cap (US$)

Bio Plus Co., Ltd

133.2M

18.78x

MSBIO, Inc.

128.4M

—

Shinhung Co., Ltd

98.56M

25.45x

Devyser Diagnostics AB…

110.6M

43.10x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

(2.369)

(2.666)

Own earn%

—

Sh yield%

(5.75)

(101.04)

Owners

Insiders/Inst%

20.73

19.11

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

0/4

Revenue growth years

3/3

EPS growth years

1/3

Dividend streakyrs

Op margin range%

−1797–−186

$1 testx

—

Incr. ROIC%

−15

Sky Labs Inc. manufactures CART BP pro, a ring-type medical device as a blood pressure monitoring solution for healthcare professionals and patients. The company provides health monitoring services to prevent chronic disease as an AI healthcare platform company. Additionally, it develops CART ON, a healthcare platform that collects, analyzes, diagnoses, and distributes data from outpatients with chronic diseases.

Growth vs revenue

Latest

Trend

3Y CAGR

Rel growth

Revenue

₩7.936B

154.64%

1.00×

Cost of revenue

₩4.026B

26.02%

0.12×

Operating expenses

₩18.64B

37.90%

0.16×

Asset mix

Trend

Cash and investments

67.64%

Other

30.31%

Goodwill & intangibles

2.05%

Reinvestment returns

No breakdown available